Drug
SR750 tablet
SR750 tablet is a pharmaceutical drug with 4 clinical trials. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_1
3
75%
Ph phase_2
1
25%
Phase Distribution
3
Early Stage
1
Mid Stage
0
Late Stage
Phase Distribution4 total trials
Phase 1Safety & dosage
3(75.0%)
Phase 2Efficacy & side effects
1(25.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(4)
Detailed Status
Completed4
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 13 (75.0%)
Phase 21 (25.0%)
Trials by Status
completed4100%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_2
Efficacy, Safety, and Tolerability of SR750 in Patients With Trigeminal Neuralgia
NCT06571448
completedphase_1
The Pharmacokinetics (PK), Safety, Tolerability of SR750 (Formulation F1) in Healthy Volunteers
NCT06932536
completedphase_1
The Pharmacokinetics (PK), Safety, Tolerability of SR750 in Healthy Volunteers
NCT05753033
completedphase_1
The Safety, Tolerability, and Pharmacokinetics (PK) of SR750 in Healthy Volunteers
NCT05083468
Clinical Trials (4)
Showing 4 of 4 trials
NCT06571448Phase 2
Efficacy, Safety, and Tolerability of SR750 in Patients With Trigeminal Neuralgia
NCT06932536Phase 1
The Pharmacokinetics (PK), Safety, Tolerability of SR750 (Formulation F1) in Healthy Volunteers
NCT05753033Phase 1
The Pharmacokinetics (PK), Safety, Tolerability of SR750 in Healthy Volunteers
NCT05083468Phase 1
The Safety, Tolerability, and Pharmacokinetics (PK) of SR750 in Healthy Volunteers
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4